Spiggle & Theis Mt Gmbh recalls Injection needle, bayonet, Luer-Lock, 1. Model no. 50-353-23…
Model no. 50-353-23, working length 25 cm, total length 31cm, nonsterile; 2.
Spiggle & Theis Mt Gmbh began a medical device recall on June 27, 2025 whose reported distribution included Ohio. FDA
What the record shows
Model no. 50-353-23, working length 25 cm, total length 31cm, nonsterile; 2. Model no. 50-345-23, working len… beginning June 27, 2025, in a medical device recall whose distribution included Ohio. The stated reason: Affected product show elevated cytotoxicity values. Use of affected injection needles may present a risk of intolerance reaction or allergic reaction. FDA graded it Class II — use may cause temporary or medically reversible health consequences. Quantity affected: N/A. The recall is listed as ongoing. FDA
Context
By the numbers
- Date of record: June 27, 2025 FDA
- Recall number: Z-2331-2025 FDA
- Recalls in this action: 1 FDA
- Recalling firm: Spiggle & Theis Mt Gmbh FDA
- Product: Injection needle, bayonet, Luer-Lock, 1. Model no. 50-353-23, working length 25 cm, total length 31cm, nonsterile; 2.… FDA
- Reason for recall: Affected product show elevated cytotoxicity values. Use of affected injection needles may present a risk of… FDA
Assembled mechanically from the source filing and The Lantern's own record database — no AI-written prose. Every figure above appears verbatim in the cited record, which is linked on this page. FDA
Sources
The source filing
| Recall number | Z-2331-2025 |
|---|---|
| Recalls in this action | 1 |
| Recalling firm | Spiggle & Theis Mt Gmbh |
| Product | Injection needle, bayonet, Luer-Lock, 1. Model no. 50-353-23, working length 25 cm, total length 31cm, nonsterile; 2. Model no. 50-345-23, working length 24 cm, total length 31 cm, non-sterile |
| Reason for recall | Affected product show elevated cytotoxicity values. Use of affected injection needles may present a risk of intolerance reaction or allergic reaction. |
| Classification | Class II — use may cause temporary or medically reversible health consequences |
| Recall type | medical device |
| Quantity | N/A |
| Status | Ongoing |
| Voluntary or mandated | Voluntary: Firm initiated |
| Initiated | 20250627 |
| Reported | 20250827 |
| Distribution | US Nationwide distribution in the states of California, Connecticut, Missouri, and Ohio. |
| Firm location | Dieburg, N/A, Germany |
Published by U.S. Food and Drug Administration (openFDA). This is the agency's public filing as The Lantern received it, shown with its fields named in plain English.